Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotype

Detalhes bibliográficos
Autor(a) principal: Trombetta, Amelia Chiara
Data de Publicação: 2021
Outros Autores: Farias, Guilherme B., Gomes, André, Godinho-Santos, Ana, Rosmaninho, Pedro, Conceição, Carolina M., Laia, Joel, Santos, Diana F., Almeida, Afonso, Mota, Catarina, Gomes, Andreia, Montesinos Serrano, Marta, Veldhoen, Marc, Sousa, Ana E., Fernandes, Susana M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/57629
Resumo: Copyright © 2021 Trombetta, Farias, Gomes, Godinho-Santos, Rosmaninho, Conceição, Laia, Santos, Almeida, Mota, Gomes, Serrano, Veldhoen, Sousa and Fernandes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
id RCAP_0ae3fd17c3ff67635e1d1eec2f0f8503
oai_identifier_str oai:repositorio.ul.pt:10451/57629
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotypeCOVID-19M2-like differentiationSARS-CoV-2Immune-regulationInnate immunityCopyright © 2021 Trombetta, Farias, Gomes, Godinho-Santos, Rosmaninho, Conceição, Laia, Santos, Almeida, Mota, Gomes, Serrano, Veldhoen, Sousa and Fernandes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell activation and phenotype leading to recovery in patients surviving severe COVID-19. We evaluated longitudinally patients with COVID-19 related respiratory insufficiency, stratified according to the need of intensive care unit admission (ICU, n = 11, and No-ICU, n = 9), and age and sex matched healthy controls (HCs, n = 11), by flow cytometry and a wide array of serum inflammatory/immune-regulatory mediators. All patients featured systemic immune-regulatory myeloid cell phenotype as assessed by both unsupervised and supervised analysis of circulating monocyte and dendritic cell subsets. Specifically, we observed a reduction of CD14lowCD16+ monocytes, and reduced expression of CD80, CD86, and Slan. Moreover, mDCs, pDCs, and basophils were significantly reduced, in comparison to healthy subjects. Contemporaneously, both monocytes and DCs showed increased expression of CD163, CD204, CD206, and PD-L1 immune-regulatory markers. The expansion of M2-like monocytes was significantly higher at admission in patients featuring detectable SARS-CoV-2 plasma viral load and it was positively correlated with the levels of specific antibodies. In No-ICU patients, we observed a peak of the alterations at admission and a progressive regression to a phenotype similar to HCs at discharge. Interestingly, in ICU patients, the expression of immuno-suppressive markers progressively increased until discharge. Notably, an increase of M2-like HLA-DRhighPD-L1+ cells in CD14++CD16- monocytes and in dendritic cell subsets was observed at ICU discharge. Furthermore, IFN-γ and IL-12p40 showed a decline over time in ICU patients, while high values of IL1RA and IL-10 were maintained. In conclusion, these results support that timely acquisition of a myeloid cell immune-regulatory phenotype might contribute to recovery in severe systemic SARS-CoV-2 infection and suggest that therapeutic agents favoring an innate immune system regulatory shift may represent the best strategy to be implemented at this stage.The Research was funded by Fundação para a Ciência e Tecnologia (FCT), “APOIO ESPECIAL RESEARCH 4COVID-19” projects 803, 125, 231_596873172, and 729. AMCG and GF received fellowships funded by FCT (DOCTORATES4COVID-19, 2020.10202.BD), and JANSSEN- CILAG FARMACÊUTICA, respectively. The funder was not involved in the study design, collection, analysis, interpretation of data, writing of the article or decision to submit it for publication. MV was supported by the European Union H2020 ERA project (No 667824 – EXCELLtoINNOV). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 667824.FrontiersRepositório da Universidade de LisboaTrombetta, Amelia ChiaraFarias, Guilherme B.Gomes, AndréGodinho-Santos, AnaRosmaninho, PedroConceição, Carolina M.Laia, JoelSantos, Diana F.Almeida, AfonsoMota, CatarinaGomes, AndreiaMontesinos Serrano, MartaVeldhoen, MarcSousa, Ana E.Fernandes, Susana M.2023-05-26T13:57:03Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/57629engFront Immunol. 2021 Jun 23;12:69172510.3389/fimmu.2021.6917251664-3224info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T17:06:18Zoai:repositorio.ul.pt:10451/57629Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:08:08.520880Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotype
title Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotype
spellingShingle Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotype
Trombetta, Amelia Chiara
COVID-19
M2-like differentiation
SARS-CoV-2
Immune-regulation
Innate immunity
title_short Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotype
title_full Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotype
title_fullStr Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotype
title_full_unstemmed Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotype
title_sort Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotype
author Trombetta, Amelia Chiara
author_facet Trombetta, Amelia Chiara
Farias, Guilherme B.
Gomes, André
Godinho-Santos, Ana
Rosmaninho, Pedro
Conceição, Carolina M.
Laia, Joel
Santos, Diana F.
Almeida, Afonso
Mota, Catarina
Gomes, Andreia
Montesinos Serrano, Marta
Veldhoen, Marc
Sousa, Ana E.
Fernandes, Susana M.
author_role author
author2 Farias, Guilherme B.
Gomes, André
Godinho-Santos, Ana
Rosmaninho, Pedro
Conceição, Carolina M.
Laia, Joel
Santos, Diana F.
Almeida, Afonso
Mota, Catarina
Gomes, Andreia
Montesinos Serrano, Marta
Veldhoen, Marc
Sousa, Ana E.
Fernandes, Susana M.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Trombetta, Amelia Chiara
Farias, Guilherme B.
Gomes, André
Godinho-Santos, Ana
Rosmaninho, Pedro
Conceição, Carolina M.
Laia, Joel
Santos, Diana F.
Almeida, Afonso
Mota, Catarina
Gomes, Andreia
Montesinos Serrano, Marta
Veldhoen, Marc
Sousa, Ana E.
Fernandes, Susana M.
dc.subject.por.fl_str_mv COVID-19
M2-like differentiation
SARS-CoV-2
Immune-regulation
Innate immunity
topic COVID-19
M2-like differentiation
SARS-CoV-2
Immune-regulation
Innate immunity
description Copyright © 2021 Trombetta, Farias, Gomes, Godinho-Santos, Rosmaninho, Conceição, Laia, Santos, Almeida, Mota, Gomes, Serrano, Veldhoen, Sousa and Fernandes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-01-01T00:00:00Z
2023-05-26T13:57:03Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/57629
url http://hdl.handle.net/10451/57629
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Front Immunol. 2021 Jun 23;12:691725
10.3389/fimmu.2021.691725
1664-3224
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Frontiers
publisher.none.fl_str_mv Frontiers
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134635609817088